Your browser doesn't support javascript.
loading
A single-center comparative study of alcohol septal ablation(SA) and surgery myectomy(SM) for refractory hyper-trophic obstructive cardiomyopathy( HOCM) / 中华胸心血管外科杂志
Article in Zh | WPRIM | ID: wpr-735051
Responsible library: WPRO
ABSTRACT
Objective Septal reduction therapies were recommended for drug-refractory patients with hypertrophic ob-structive cardiomyopathy(HOCM).To explore and compare the effectiveness and safety in patients with hypertrophic obstruc-tive cardiomyopathy(HOCM) treated with surgery myectomy(SM) and alcohol septal ablation(SA).Methods The clinical data of 260 patients performed SA(n=184) or SM(n=76)between September 2002 and September 2014 in our institute were retrospectively reviewed.The t-test, rank sum test and chi-square test were used to compare the differences between the two groups, and the Cox regression model was used for multivariate survival analysis.All-cause mortality, cardiac cause death(peri-operative death were included ) , heart function improvement , procedure-related complications and permanent pacemaker de-pendence( PPM) constituted the main contents of this study .Results Compared with patients treated with SM , patients un-dergone SA were poor heart function status(2.97 ±0.29 vs 2.50 ±0.56, P =0.01), more prevalence of atrial fibrillation( 15.14% vs 6.80%, P=0.046) and longer follow-up period[(5.4 ±3.8) years vs(2.5 ±2.2) years, P =0.01)].All-cause mortality for SA and SM were 3.3% and 14.5% respectively(P=0.001).The fatal cardiac events of SA and SM were 1.63% and 13.16% respectively(P<0.001).Sudden cardiac arrest were the main cardiac cause death for both patients trea-ted with SA and SM.The cardiac death of left ventricular systolic dysfunction was main found in patients treated with SM . Heart function improvement(NYHA) after SA and SM were 1.23 ±0.61 and 0.88 ±0.64 respectively(all P <0.01).And SA had a lower procedure-related PPM implantation(1.63% vs 4.20%, P<0.05).Conclusion Our results shown that SA have survival advantage, lower PPM and similar heart function improvement compared with SM for refractory patients with HOCM.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Thoracic and Cardiovascular Surgery Year: 2019 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Thoracic and Cardiovascular Surgery Year: 2019 Type: Article